Results for
"[search-keyword]"
Sponsor content
103 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XEMBIFY normal immunoglobulin 2 g/10 mL (20%) solution for subcutaneous injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XEMBIFY normal immunoglobulin 10 g/50 mL (20%) solution for subcutaneous injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XEMBIFY normal immunoglobulin 1 g/5 mL (20%) solution for subcutaneous injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 4000 mg solution for injection for intravenous infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 500 mg solution for injection for intravenous infusion vial.
-
Australian Public Assessment Report (AusPAR)AusPAR for Xembify (human normal immunoglobulin) for the treatment of primary immunodeficiency diseases.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Immunohaematology blood grouping antisera IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VeraSeal solutions for sealant 6 mL (Human fibrinogen 80 mg/mL syringe 3 ml / Human thrombin 500 IU/mL syringe 3 ml).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VeraSeal solutions for sealant 4 mL (Human fibrinogen 80 mg/mL syringe 2 ml / Human thrombin 500 IU/mL syringe 2 ml).